Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Medical Oncology × anetumab ravtansine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Mesothelioma 3 Pancreatic Neoplasms 2 Neoplasms 2 Lung Neoplasms 2 Carcinoma, Non-Small-Cell Lung 2 Triple Negative Breast Neoplasms 1 Thymoma 1 Ovarian Neoplasms 1 Medical Oncology 1 Fallopian Tube Endometrioid Adenocarcinoma 1 Cholangiocarcinoma 1 Adenocarcinoma of Lung 1

Interventions

Itraconazole 2 roniciclib 1 aprutumab ixadotin 1 anetumab ravtansine 1 Diet 1 Control Groups 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02824042 2020-07-31

Thorough ECG (Electrocardiogram) and Drug Interaction Study With Anetumab Ravtansine and Itraconazole

Bayer

Phase 1 Completed

Medical Oncology

Data powered by HemOnc (CC BY 4.0) Colophon ⚡